The company is outgrowing its own explanations: management keeps telling investors the reported numbers are not the busi
The model's full reasoning — Q3 2021 call → NO我们根据提供的财报电话会议记录,判断管理层是否传达出报告期(2021年第三季度)的结果不代表公司当前实际运营的业务,即报告期已经过时,公司现在已经领先于报告数字。 分析管理层言论: - 管理层多次强调公司持续改进,如AVA平台改进、新模块实施、新市场推出、新合作伙伴关系(如Cedars-Sinai等)在2022年生效。 - 提到AEP(年度选举期)刚开始,新会员增长将在未来体现。 - 提到第四季度将投入更多费用用于增长,如新市场、新员工。 - 提到DCE(直接承包实体)项目仍在早期,需要更多数据。 - 提到2022年展望将在AEP结束后分享。 但关键问题是:管理层是否明确表示报告期数字已经落后于当前业务?他们是否指出当前业务已经超越报告期?从记录看,管理层主要是在报告强劲的第三季度业绩,并展望未来,但并未明确说“报告期不代表当前业务”或“当前业务已经领先于报告期”。他们提到的一些投资和增长是常规的,没有强调报告期已经过时。 例如,他们提到“我们继续投资于业务智能模块”,但这是持续改进,不是指出报告期落后。他们提到“我们正在推出新市场”,但这是未来计划。他们提到“AEP刚开始”,但这是未来销售。 管理层没有明确说“报告期数字已经不能反映公司现状”,而是强调第三季度表现强劲,并给出第四季度和全年指引。他们提到的一些费用将在第四季度发生,但这是正常的时间安排。 因此,答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| VRE | Veris Residential, Inc. | Q4 2022 | 2023-02-22 | D |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
VRE · Q4 2022 → YESThe question is: Does management convey that the reported results for the period do not represent the business the company is actually running today? That the just-reported numbers describe a company ...YES The transcript shows management repeatedly framing the reported period as transitional and not reflective of the current business: the shift to a pure-play multi-family company has already reduced office and hotel exposure while driving multi-family NOI share to 98%, with Haus25 leased at 95% ahead of schedule and same-store NOI guidance of 4-6% for 2023. They explicitly note that earnings variability stems from the ongoing asset sales and reallocation, with the business now positioned for growth as the transformation concludes, and they highlight post-period activity like additional sales and stabilized properties to underscore that the reported numbers capture a pre-transition state.
PFE · Q4 2023 → YESThe question is: Does management convey that the reported results do not represent the business the company is actually running today? That the just-reported numbers describe a company that has alread...NO The transcript shows management framing 2023 results as a challenging year with declines driven by COVID products, while positioning 2024 as a year of execution and growth through new priorities like the Seagen acquisition (closed late in 2023 with minimal contribution) and new product launches. This is a standard results-and 2024 outlook discussion, with forward-looking elements on pipeline, margins, and capital allocation rather than indicating the reported period is stale relative to current operations.
PRIM · Q2 2018 → YESThe question is whether management conveys that the reported results for Q2 2018 do not represent the business the company is actually running today. Specifically, if the printed period is stale relat...YES The transcript shows management repeatedly framing the Q2 results as a partial picture due to the late June 1 acquisition of Willbros. They note the business is "running as planned," highlight one-month revenue contribution of $1.